CIK 0000832489 · Non-accelerated filer<br>Smaller reporting company
GeoVax Labs, Inc.
Sign in to watch- Ticker
- GOVX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870455038
- Phone
- 678-384-7220
- Business address
- 1955 LAKE PARK DRIVE, SUITE 300, SMYRNA, GA
- Former names
- DAUPHIN TECHNOLOGY INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-29 | Reynolds Mark CFO | Purchase | +60,184 | $5.00 | $301K | 60,184 |
| 2020-09-29 | Reynolds Mark CFO | Purchase · Common Stock Purchase Warrant | +60,184 | 60,184 | ||
| 2020-09-29 | DODD DAVID A President, CEO | Purchase | +81,870 | $5.00 | $409K | 81,870 |
| 2020-09-29 | DODD DAVID A President, CEO | Purchase · Common Stock Purchase Warrant | +81,870 | 81,870 | ||
| 2020-09-29 | MCNALLY ROBERT T Director | Purchase | +53,925 | $5.00 | $270K | 53,925 |
| 2020-09-29 | MCNALLY ROBERT T Director | Purchase · Common Stock Purchase Warrant | +53,925 | 53,925 | ||
| 2020-09-29 | SPENCER JOHN N JR Director | Purchase | +21,024 | $5.00 | $105K | 21,024 |
| 2020-09-29 | SPENCER JOHN N JR Director | Purchase · Common Stock Purchase Warrant | +21,024 | 21,024 | ||
| 2020-09-29 | Kollintzas Dean G Director | Purchase | +11,987 | $5.00 | $60K | 11,987 |
| 2020-09-29 | Kollintzas Dean G Director | Purchase · Common Stock Purchase Warrant | +11,987 | 11,987 | ||
| 2020-09-29 | CHASE RANDAL D Director | Purchase | +16,613 | $5.00 | $83K | 16,613 |
| 2020-09-29 | CHASE RANDAL D Director | Purchase · Common Stock Purchase Warrant | +16,613 | 16,613 | ||
| 2018-12-17 | SPENCER JOHN N JR Director | Grant or award · Common Stock Purchase Option | +345,000 | 345,000 | ||
| 2018-12-17 | MCNALLY ROBERT T Director | Grant or award · Common Stock Purchase Option | +650,000 | 650,000 | ||
| 2018-12-17 | Kollintzas Dean G Director | Grant or award · Common Stock Purchase Option | +300,000 | 300,000 | ||
| 2018-12-17 | CHASE RANDAL D Director | Grant or award · Common Stock Purchase Option | +320,000 | 320,000 | ||
| 2018-12-17 | ROBINSON HARRIET L CSO Emeritus | Grant or award · Common Stock Purchase Option | +600,000 | 600,000 | ||
| 2018-12-17 | Reynolds Mark CFO | Grant or award · Common Stock Purchase Option | +750,000 | 750,000 | ||
| 2018-12-17 | Guirakhoo Farshad Chief Scientific Officer | Grant or award · Common Stock Purchase Option | +625,000 | 625,000 | ||
| 2018-12-17 | DODD DAVID A President, CEO | Grant or award · Common Stock Purchase Option | +785,000 | 785,000 |
Page 5 of 6 · 107 trades